SCHEMBL21891752

SCHEMBL21891752

CC(NC(=O)Oc1ccccc1)OC(=O)CCC(NC(=O)Oc1ccccc1)C(O)OC(C)NC(=O)Oc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CYP1A2 P05177 2/20 0.39
GAA P10253 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
FAAH O00519 1/20 0.39
SLC1A3 P43003 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 6/20 0.37
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
MTNR1A P48039 3/20 0.36
MTNR1B P49286 3/20 0.36
SIRT1 Q96EB6 2/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
BCHE P06276 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21892083 0.82 CYP1A2 (0.45) MEN1KMT2ACYP1A2GAACYP3A4
SCHEMBL21891749 0.80 CYP1A2 (0.43) MEN1KMT2ACYP1A2GAACYP3A4
SCHEMBL21891842 0.75 CYP1A2 (0.44) MEN1KMT2ACYP1A2GAACYP3A4
SCHEMBL23515435 0.75 NPC1 (0.38) MEN1KMT2ACYP1A2GAACYP3A4
SCHEMBL23130350 0.73 NPC1 (0.37) MEN1KMT2ACYP1A2GAACYP3A4
SCHEMBL19189362 0.72 CYP1A2 (0.50) MEN1KMT2ACYP1A2GAACYP3A4
SCHEMBL23130348 0.71 CYP1A2 (0.40) MEN1KMT2ACYP1A2GAACYP3A4
SCHEMBL23515530 0.70 FAAH (0.38) CYP1A2GAAFAAHSLC1A3NPC1
SCHEMBL23130312 0.70 FAAH (0.38) CYP1A2GAAFAAHSLC1A3NPC1
SCHEMBL1849668 0.69 SLC1A3 (0.56) MEN1KMT2ACYP1A2GAACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968168-B2 Isocyanate production method ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-04-06 US disclosed
US-20200115327-A1 ISOCYANATE PRODUCTION METHOD ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115327-A1 ISOCYANATE PRODUCTION METHOD IDH3A, ALKBH3, CPS1 MEN1 2818/4885KMT2A 349/4885CYP1A2 184/4885
US-10968168-B2 Isocyanate production method IDH3A, ALKBH3, CPS1 MEN1 2818/4885KMT2A 349/4885CYP1A2 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.